These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
381 related items for PubMed ID: 8604455
1. Options in the management of pneumonia caused by Pneumocystis carinii in patients with acquired immune deficiency syndrome and intolerance to trimethoprim/sulfamethoxazole. Korraa H, Saadeh C. South Med J; 1996 Mar; 89(3):272-7. PubMed ID: 8604455 [Abstract] [Full Text] [Related]
2. Treatment of Pneumocystis carinii pneumonia in patients with AIDS. Wordell CJ, Hauptman SP. Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063 [Abstract] [Full Text] [Related]
3. Treatment of Pneumocystis carinii pneumonia in adults with AIDS. Deresinski SC. Semin Respir Infect; 1997 Jun; 12(2):79-97. PubMed ID: 9195673 [Abstract] [Full Text] [Related]
4. Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study. Helweg-Larsen J, Benfield T, Atzori C, Miller RF. J Antimicrob Chemother; 2009 Dec; 64(6):1282-90. PubMed ID: 19858161 [Abstract] [Full Text] [Related]
5. Treatment and prophylaxis of Pneumocystis carinii pneumonia. Castro M. Semin Respir Infect; 1998 Dec; 13(4):296-303. PubMed ID: 9872626 [Abstract] [Full Text] [Related]
8. Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study Group. Safrin S, Finkelstein DM, Feinberg J, Frame P, Simpson G, Wu A, Cheung T, Soeiro R, Hojczyk P, Black JR. Ann Intern Med; 1996 May 01; 124(9):792-802. PubMed ID: 8610948 [Abstract] [Full Text] [Related]
10. The role of atovaquone tablets in treating Pneumocystis carinii pneumonia. Hughes WT. J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Mar 01; 8(3):247-52. PubMed ID: 7859136 [Abstract] [Full Text] [Related]
11. Treatment of infection due to Pneumocystis carinii. Fishman JA. Antimicrob Agents Chemother; 1998 Jun 01; 42(6):1309-14. PubMed ID: 9624465 [No Abstract] [Full Text] [Related]
12. A meta-analysis of salvage therapy for Pneumocystis carinii pneumonia. Smego RA, Nagar S, Maloba B, Popara M. Arch Intern Med; 2001 Jun 25; 161(12):1529-33. PubMed ID: 11427101 [Abstract] [Full Text] [Related]
13. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia. Warnock AC, Rimland D. Pharmacotherapy; 1996 Jun 25; 16(6):1030-8. PubMed ID: 8947975 [Abstract] [Full Text] [Related]
14. Efficacies of atovaquone, pentamidine, and trimethoprim/sulfamethoxazole for the prevention of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases. Kitazawa T, Seo K, Yoshino Y, Asako K, Kikuchi H, Kono H, Ota Y. J Infect Chemother; 2019 May 25; 25(5):351-354. PubMed ID: 30711257 [Abstract] [Full Text] [Related]